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Testing an implementation strategy bundle
on adoption and sustainability of evidence
to optimize physical function in
community-dwelling disabled and older
adults in a Medicaid waiver: a multi-site
pragmatic hybrid type III protocol
Sandra L. Spoelstra1* , Monica Schueller1 and Alla Sikorskii2

Abstract
Background: In partnership with a state Medicaid home and community-based waiver program, this study tests
implementation strategies for adoption and sustainability of an evidence-based intervention to support disabled
and older adults who have difficulty with physical function and daily living tasks. A multi-level implementation
strategy bundle will be directed at relationship, coalition, and team building; readiness to implement, leadership,
and clinician attitude toward evidence assessments; intervention and facilitation training; interdisciplinary
coordination; facilitation; and audit and feedback to support practice change.
Methods: Knowledge-to-Action model underpins this 2-arm, 3-year pragmatic mixed method randomized
hybrid type III trial in 18 waiver program sites in Michigan. Data will be collected on sites, 775 clinicians
(registered nurses, occupational therapists, social workers), and 15,000 disabled and older adults. Consolidated
Framework for Implementation Research guides examination of site, clinician, and beneficiary characteristics;
clinician attitude and self-efficacy; leadership and readiness to implement; and intervention impact on
beneficiary outcomes. Sites will be randomized to either usual waiver care with internal facilitation of the
bundle of implementation strategies or usual waiver care with both internal and external facilitation of the
bundle. Primary outcomes are site-level adoption and sustainability over 12 months, and intervention effects
on these outcomes are hypothesized to be mediated by clinicians’ attitude and self-efficacy. At the beneficiary level, by
addressing the individual’s capabilities and home environment, the intervention is hypothesized to improve secondary
outcomes of activities of daily living, pain, depression, falls, emergency department visits, and hospitalizations. Baseline
site readiness and leadership and stages of implementation at 6 months will be explored as potential moderators.
Linear mixed effects models will be used to test intervention effects on primary outcomes, with bias-correcting analytic
strategy in mediation analyses. Generalized linear mixed effects modeling will be employed for the analysis of
intervention effects on secondary outcomes.
(Continued on next page)

* Correspondence: spoelsts@gvsu.edu
1
Kirkhof College of Nursing, Grand Valley State University, 301 Michigan St,
Room C352, Grand Rapids, MI 49504, USA
Full list of author information is available at the end of the article
© The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Spoelstra et al. Implementation Science

(2019) 14:60

Page 2 of 13

(Continued from previous page)

Discussion: Synthesizing findings within and across the sites, we will specify how leadership, readiness for change, and
level of facilitation enhance capacity for adoption and sustainability of an evidence-based intervention in an underresourced Medicaid setting that cares for disabled and older adults.
Trial registration: ClinitalTrials.gov, NCT03634033. Registered 16 August 2018.
Keywords: Adoption, Sustainability, Implementation, Implementation strategies, Physical function, Communitydwelling, Older adults, Medicaid waiver, Study protocol, Randomized controlled trial,

Contributions to the literature
 This trial will provide immediate impact on the waiver by
providing access to an evidence-based intervention that
improves physical function and the ability to perform daily
tasks, and assists disabled and older adults to remain living
in the community.

 A long-term impact will be to enhance the waiver’s capacity

Model guiding implementation

The Knowledge-to-Action [18, 19] model underpins our
approach (see Fig. 1) to implementation. Evidence was
created and efficacy established by others [7–10]. In prior
work, the evidence-based intervention was selected,
barriers to implementation were identified, and the intervention was adapted to the setting and population [6].
This study will evaluate adoption and sustainability of the
intervention and beneficiary outcomes.

for practice innovations through development and testing of
a bundle of implementation strategies to enhance adoption
and sustainability of evidence-based interventions.

 The trial will specify stages of implementation completion
and how leadership, readiness for change, clinician attitude,
and self-efficacy enhance capacity for practice improvement
and adoption of evidence-based programs.

Background
There are 962 million people aged 60 and older worldwide
[1], and 42% in the USA report problems with physical
function, which can lead to difficulty with daily tasks and
nursing home placement [2–5]. Interventions that optimize
physical function to support aging-in-place are needed, particularly in settings that care for disabled and older adults.
We propose to address this urgent need through the testing
of an implementation strategy bundle on adoption and sustainability of an adapted intervention [6] that improves
adults’ ability to conduct daily tasks [7–10]. The implementation strategy bundle includes relationship, coalition, and
team building; readiness to implement, leadership, and clinician attitude toward evidence assessments; intervention
and facilitation training; interdisciplinary coordination;
internal and external facilitation (IF, EF); and audit and
feedback. Multi-level approaches are known to support
incremental single strategy effects, as well as a synergistic
effect from all the strategies [11]. Thus, we test two topics
of import to the field of implementation science - adoption
and sustainability [12–16] - and explore mechanisms of
action [17] to support uptake, while implementing a
complex multi-component intervention in a disabled aging
population. Real practice change and improved outcomes
will not occur without adoption and sustainability [13].

Methods
The overall goal of the study is to implement evidence
in a waiver program to improve the ability of disabled or
older adults to perform daily tasks. Objectives for this
study are to test the deployment of an implementation
strategy bundle on adoption and sustainability of the
intervention and to examine the effect of the intervention on beneficiary outcomes.

Aims

Aim 1: To test the effects of an implementation strategy
bundle with IF alone versus an implementation strategy
bundle with IF + EF with respect to the site-level
outcomes of adoption and sustainability (primary) and
beneficiary-level outcomes of activities of daily living/instrumental activities of daily living (ADL/IADLs), pain,
depression, falls, emergency department (ED) visits, and
hospitalizations (secondary) over the next 12 months.
Aim 2 mechanism-of-action: To determine whether the
effects of IF + EF versus IF on primary outcomes are
mediated by clinician attitude or self-efficacy at 9 months.
Aim 3: To benchmark the effects of IF and IF + EF on
beneficiary outcomes following implementation as compared to pre-intervention.
Exploratory aim 4: To compare the primary and
secondary outcomes within 12 months, potential mediators at 9 months, and baseline leadership and readiness for
sites with SIC of > 50% versus sites with SIC of < 50%
at 6 months in each arm.
Exploratory aim 5: To explore whether baseline site
leadership and readiness moderate the impact of IF + EF
compared to IF on primary and secondary outcomes
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Fig. 1 Applying the Knowledge-to-Action model to the intervention creation, testing, setting/population, adaptation, barriers, and knowledge use

within 12 months in order to determine which sites may
require facilitation that is more intensive.
Exploratory aim 6: To evaluate clinician satisfaction at
1 month and the cost of implementation and policy impact for IF and IF + EF at 12 months.
Study design

Testing in this study will occur in a 2-arm, 3-year pragmatic hybrid type III [20, 21] mixed method randomized
trial design [22–24]. Hybrid III trials examine implementation strategy effect (primary) while gathering data on
the intervention outcomes (secondary) [21].
Arm 1 includes usual waiver care and an implementation strategy bundle with IF.
Arm 2 includes all components of Arm 1 plus additive EF.
Setting

The setting is 18 Medicaid home and community-based
(MI Choice) waiver sites in Michigan. The waiver supports low-income, nursing home eligible, disabled, and
older adults in the community, providing 19 services
(e.g., personal care and meals) through registered nurse
(RN) and social work (SW) case management.
Participants, recruitment, contracts, and consents

We have three levels of participation: the site, the
clinician, and Medicaid beneficiary, with individualized
recruitment plans for each. Figure 2 shows a CONSORTlike flow chart of recruitment by site, clinician, and
beneficiary.
Sites. We recruited 18 waiver sites in Michigan, have
letters of support, and anticipate all will be contracted.

Clinicians. We will recruit clinicians via a flyer sent by
email. In addition, the IF at each site will encourage clinicians to complete the training and use the intervention
by providing verbal and written prompts during routine
communications (email or face-to-face) and at staff
meetings. We expect 80% (620 of 775) of clinicians
employed at the sites to consent electronically prior to
online training, complete the training, and use the intervention with beneficiaries.
Beneficiaries. The trained clinicians will recruit beneficiaries during a home visit using an algorithm that was
designed during prior work and a cognitive aid on a
pocket card that will be provided during training. The
algorithm is a set of rules the clinician follows to use
critical thinking when examining the beneficiary’s need
or potential benefit from the intervention. We expect
60% (9,000 of 15,000) of beneficiaries to not opt-out and
receive the intervention.
Inclusion criteria

Sites. Eighteen sites under contract by the Michigan
Medicaid program which provide waiver care and
utilize an electronic health record (EHR) from EHR
company are included. Excluded are 2 sites which do not
use the EHR.
Clinicians. Clinicians who are employed by the sites
who consent and are trained in use of the intervention
are included. Excluded are clinicians who do not consent
and/or do not complete the training.
Beneficiaries. Beneficiaries who do not opt-out and
who may need and benefit from the care will receive
the intervention. Excluded are beneficiaries who
opt-out.
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Fig. 2 CONSORT-like figure of recruitment and participant status to be tracked. a Site CONSORT-like figure. b Clinician study status CONSORT-like
figure. c Beneficiaries study status CONSORT-like figure

Evidence-based intervention

The evidence-based intervention reduces the effect of
problems with physical function among low-income older
adults living in the community by addressing an individual’s capabilities and the home environment [7–10]. The
intervention is a 16-week structured program delivered by
occupational therapists (OTs) who conduct 6 home visits
and provide assistive devices, RNs who conduct 4 home
visits, and a handyman who provides home alterations
(e.g., installs devices, environmental modifications, and
home repair). The team provides consultation with older
adults to help the individuals identify daily activity goals
(e.g., taking a shower and walking to the bathroom), evaluates barriers to achieving those goals, and attains outcomes collaboratively. OTs assist older adults to carry out
ADLs, IADLs, and discretionary activities that are challenging at home such as functional mobility, meal preparation, bathing, and dressing. RNs target underlying issues
that influence ADLs and IADLs, such as pain reduction,
improvement in mood, fall prevention, incontinence
management, and medication review and management
with the help of a pharmacist. In prior work, the intervention was adapted [6] to fit the waiver setting and

population: SWs were added to address social and emotional needs; the number, type, and timing of clinician
visits were tailored to the beneficiary’s need; RNs were
trained in medication management; and training and
documentation modes were modified to fit the setting.
Guiding framework

Consolidated Framework for Implementation Research
[25, 26] supports our approach to practice change (see
Fig. 3). We will examine characteristics (site, clinician,
and beneficiary), clinician attitude and self-efficacy, inner
setting [27] leadership and readiness to implement, and
outer setting [28] policy, as each may impact adoption
and sustainability.
Implementation strategies

We will deploy a 9-component implementation strategy
bundle (see Table 1). As few studies focus on sustainability of implementation efforts in knowledge translation
during implementation, we examine the mechanisms of
action of awareness, commitment, confidence, and trust
[17] during implementation (see Fig. 4). Materials;
procedures; providers; mode, where provided; duration;
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Fig. 3 Consolidated Framework for Implementation Research (CFIR) factors influencing implementation strategy bundle and outcomes

intensity and dose; and tailoring, if needed, for each strategy are presented. We also delineate which strategies we
expect to trigger the mechanisms of action.
Strategy 1 We will form both informal and formal relationships to conduct this study. We expect this strategy
to prompt the mechanisms of action of trust (see Fig. 4).
Informal relationships. Informal relationships were built
between the sites, the investigator, and the state policymakers during 20 years of prior work. During this study,
the investigator will continue to interact with the policymakers on a monthly basis, updating on study progress
via a brief email (< 120 words); with the sites on a quarterly basis, providing a 1-h continuing education unit (e.g.,
incontinence, pain management); and with both by
attending the 1-h face-to-face meeting when requested.
Formal relationships. For this study, an agreement,
memorandum of understanding, or contract (site and
university, state and university, and EHR company and
university) will be executed prior to data collection and
last for the duration of the study. The roles and responsibilities of each partner (site, investigator, state, and
EHR company), a data use agreement, and a timeline for
the study will be delineated. A key component of the

success of the study is the IF. Delineated in the contract
is the selection of the IF by the investigator with
guidance by the site managers. The IFs are supervisors/employees that work for the waiver site and
will conduct facilitation at their site as “Champions.” In
addition, we will utilize a waiver employee as the EF, who
was an early adopter of the intervention in prior work, as
a “Super-Champion” for arm 2.
Strategy 2 Data on readiness to implement, to prompt
the mechanisms of action of awareness (see Fig. 4), and
leadership, to examine the need to do intermittent booster
training for facilitators, will be collected from clinicians in
an online 10-min survey distributed prior to training.
Within the readiness assessment, we focus on subscales of
training, pressure for change, and attributes of growth,
efficacy, and influence. Within the leadership assessment,
we focus on subscales of proactive, knowledgeable,
supportive and perseverant leadership.
Strategy 3 Data on clinician attitude and self-efficacy
will be collected in an online 10-min survey distributed
prior to training and at 9 months to examine changes
over time. In the self-efficacy assessment, we examine if

PI, PM, waiver
clinician

Administer tools,
analyze results

Site

Actors

Actions

Target of
action

Outcomes
affected

Dose

IFs

Online Bb forum to
build capacity, share
best implementation
strategies

IF, research team

IFs coalition to share
implementation
knowledge

Build IF coalition

Acceptability,
readiness

Surveys completed
baseline

Acceptability

1 h discussion
monthly

Before implementation

Aspects of an
organization
determine
readiness to
implement

Definition

Temporality

Organization
readiness

Domain

Clinical teams

Clinicians

Train
clinicians,
post-test,
remediate

IF for
clinicians

Clinicians

IF leads interdisciplinary
coordination, feedback
on implementation/
intervention

IF, clinicians

Training to Develop/implement
conduct
teams of clinicians who
intervention meet, reflect, and share
learnings

Clinician
training

Adoption, sustainability

5.5 h online Meet 15 min per month
Bb training per beneficiary cared for

When starting implementation
1.5 h Bb online training;
remediate prn

IFs

Identify and train train-thetrainers/IF

Research team for IF

Dynamic interactive training via
varying learning methods and
supervision focused on
implementation

IF training

Adoption,
sustainability

Weekly for 30 min to 1 h until
issues resolved

1 month after implement

IF

Assistance to IF (arm 2)

EF

Makes things easier for others:
support to change attitudes,
habits, skills, way of thinking
and working

EF centralize oversight

Table 1 Implementation strategies deployed, domains affected, definition, actors, actions/target of actions, temporality, dose, and outcome affected

Adoption, sustainability,
outcomes

Weekly results to scorecard in
Bb and IF reviews with
clinicians, EF reviews with IF

1 week after intervention and
ongoing

Clinicians

Monitor Bb and EHR, SIC
(scorecard)

PI, PM, IF, EF

Collect and summarize clinical
performance and monitor,
evaluate, and modify clinician
behavior

Audit and feedback
implementation intervention
fidelity
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Fig. 4 Relationships among mechanisms-of-action context, mechanism category, and expected outcome of implementation strategy

the training prompts improvement. In the attitude
assessment, we focus on openness, appeals of the new
intervention, willingness to using the intervention, and
conflict between clinical experience and research results
(divergence). We expect this strategy to prompt the
mechanisms of action of confidence during implementation (see Fig. 4).
Strategy 4 Clinicians will be trained in the intervention,
and supervisors (IFs and EF) will be trained in facilitation. We expect this strategy to prompt the mechanisms of action of confidence during implementation
(see Fig. 4).
Clinicians. RNs, SWs, and OTs will complete a 5.5-h,
20-module, 6-article online training program prior to
providing the intervention to beneficiaries. Clinicians are
expected to complete the training in its entirety within a
30-day time period and will receive a continuing education certificate upon completion. Modules include training
on person-environment fit, person-centered care, and
building collaborative relationships and self-efficacy. In
addition, other modules include readiness-to-change, motivational interviewing, cognitive behavioral therapy, problem solving, brainstorming, therapeutic communication,
reflection, and interdisciplinary coordination. An additional file shows this in more detail (see Additional file 1).
The role of each discipline and care to be provided are
covered, with in-depth medication management instructions, a case study, and handouts to use during care. A
pocket card cognitive aid (see Additional file 2) will be
provided to assist clinicians in tailoring care to the beneficiary’s needs and desires. We may need to tailor and/or
boost education to a specific site and/or group of clinicians on use of the intervention, with brief (20–30 min)
online training modules, after we examine fidelity to the
intervention monthly (months 2 to 12).

Facilitators. IFs and EF will complete a 1.5-h, 10module online training program on facilitation. Modules
for the IF include evidence supporting implementation
strategies, the facilitator role, quality improvement,
problem solving, how to provide feedback, use of reflection, counseling, motivational interviewing, and remediation. An additional file shows this in more detail
(see Additional file 3). An implementation toolkit will
be provided, and the plan will be reviewed. The module for the EF includes a train-the-trainer approach
for facilitation of IFs. We may need to tailor and/or
boost education with some or all of the IFs if data on
implementation strategy fidelity show implementation
is not occurring as expected.
Strategy 5 IFs will form a coalition to support implementation. Monthly for 1 h for 12 months, the IFs will have an
online collaborative meeting hosted by the investigator.
The purpose of the coalition is to build capacity among
the IFs by sharing best practice use of the implementation
strategies. The investigator will provide feedback on the
number of clinicians trained and fidelity to implementation strategies and the intervention. Discussion will then
occur among the group on use of implementation strategies to improve implementation. We expect this strategy
to prompt the mechanisms of action of commitment during implementation (see Fig. 4).
Strategy 6 IFs will prompt and lead intermittent interdisciplinary coordination among the clinicians (RN, SW, and
OT), as needed, to promote teamwork, brainstorming,
and problem solving to support beneficiary goal attainment. We expect interdisciplinary coordination will occur
via phone, email, and/or face-to-face for 15 min per
month for each beneficiary cared for. However, this is
dependent upon the complexity of the beneficiary’s care
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Table 2 Measures deployed in study by domain, construct, concept, aim, who/how measured, and who collects
Framework

Construct

Concept(s)

Aim(s) Who measured

How measured

Collector

Inner setting

Readiness for
Implementation

Leadership engagement

5

ILS

Project
manager

Sites

Readiness to implement

ORC

Size of site waiver agency

Administrative
data 2018

Quality scores
Individual:site Demographics
and person

Site: number of employees/
beneficiaries, quality scores, cost

Quality data
–

Clinician: age, race, sex, discipline,
degree, years of experience as
clinician and in WA

Administrative
data 2018

Clinician

Survey

Project
manager

Beneficiary

MDS-HC

–

Attitude, self-efficacy

2

Clinician

1. EBPAS
2. GSE

Project
manager

Beneficiary outcomes

ADLs, IADLs falls, pain,
depression/ED/hospital

3 and
4

Beneficiary

MDS-HC

–

Training

Knowledge with intervention

2

Clinician

Survey

Project
manager

Team building

Inner setting

Sites

Clinician: engagement

Beneficiary: age, sex, race

Process

–

Knowledge with IF/EF

IF/EF

Interdisciplinary coordination

Beneficiary

EHR progress
notes

–

IF

Data tool

–

Clinician

Type, date,
number done

Project
manager

IF/EF

IF data tool

Research
assistants

Coalition building

Occurrence/type

Adoption

Fidelity to training

1 and
2

Fidelity to IF/EF
Fidelity to intervention

Beneficiary/patient

EHR care plan

–

Sustainability

Fidelity to change

Sites

SIC

Research
assistants

Acceptability

Satisfaction with training

6

Clinician IF EF

Survey

Project
manager

Cost

Dollars expended

6

Clinician IF EF
beneficiary

Wages, benefits

Project
manager

Payment for incentive

6

CMS contract

Contract 1 October
2022

Project
manager

Outer setting Policy

and is tailored in time and intensity based on the needs of
the person. We expect this strategy to prompt the mechanisms of action of commitment during implementation
(see Fig. 4).
Strategy 7 IFs will facilitate clinician implementation at
each site in arm 1 and 2, and the EF will facilitate IFs in
arm 2 tailored to a site’s needs. We expect that an IF will
spend between 2 to 5 h a week per month (months 2 to
12) facilitating implementation via face-to-face, email, or
phone. Also, we expect that an IF will spend 1 h a month
for 12 months interacting with IFs from other sites to
learn best practices for implementation. Once the clinicians are trained and using the intervention with the
beneficiaries, the IFs will be absorbed within usual IF
duties. IF actions include training, coaching, consultation, supervision, modeling, problem solving, and

providing feedback, supporting, instructing, demonstrating, and assisting with evaluation. We will use an audit
tool with these actions to examine facilitation monthly
(months 2 to 12) (see Additional file 4). We expect this
strategy to prompt the mechanisms of action of commitment during implementation (see Fig. 4).

Strategy 8 An audit of implementation strategy and
intervention fidelity (see Additional file 5) with feedback
will occur to assist IF’s work with clinicians in arms 1
and 2. The audit will be conducted by the study team, and
feedback will be provided to the IFs weekly via email and
reviewed monthly during the online coalition meeting for
both arm 1 and 2. We expect this strategy to prompt the
mechanisms of action of confidence, commitment, and
trust during implementation (see Fig. 4).
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Table 3 Data collection activity, month, where obtained from (state, clinicians, IF, EF, EHR), and what obtained

Strategy 9 The EFs work with and support the IFs in
arm 2. Feedback will be provided to the EF weekly via
email by the study team, with a request to provide external
facilitation as needed when implementation is not occurring as expected. Similar to IF actions, EF actions include
training, coaching, consultation, supervision, modeling,
problem solving, and providing feedback, supporting,
instructing, demonstrating, and assisting with evaluation.
We will use an audit tool with these actions to examine facilitation monthly (months 2 to 12) (see Additional file 4).
We expect this strategy to prompt the mechanisms of
action of commitment during implementation (see Fig. 4).
Measures

In this study, we will measure site, clinician, and beneficiary level data (see Table 2). Site measures include characteristics, leadership, readiness to implement, and
implementation completion. Clinician measures include
characteristics, attitude toward evidence-based care, selfefficacy, and training completion. Beneficiary measures
include characteristics and outcomes. We also measure
fidelity to implementation strategies and the intervention. Measures are shown in Table 2, and the data
collection plan is shown in Table 3.
Characteristics Characteristics will be collected at baseline. Site characteristics include size; quality scores;
number of supervisors, clinicians, and beneficiaries; and
years in the waiver. Clinician characteristics include age,
race, gender, discipline, and years working at waiver
program site. Beneficiary characteristics include age,
gender, and race.

Tools We use 6 tools in this trial. Implementation Leadership Scale (ILS) is a 12-item, 4-subscale (Cronbach .93–.97)
tool that assesses leadership behaviors and actions and
will be collected from clinicians at baseline [29, 30].
Organizational Readiness for Change (TCU-ORC) is a
124-item tool with subscales (needs of clinician, program,
training, pressure for change, resources, and attributes)
and 3-open ended questions and will be collected at baseline from clinicians (Cronbach .88) [31]. Evidence-Based
Practice Attitude Scale (EBPAS) is a 50-item tool with 12
subscales with 4 constructs (openness, appeal, requirements, and divergence) and will be collected from clinicians at baseline and 9 months [32]. General Self-Efficacy
(GSE) is a 10-item tool (Cronbach’s alpha .79–.90) and will
be collected from clinicians at baseline and 9 months [33].
Minimum Data Set-Home Care (MDS-HC) is a selfreported, person-centered assessment for the collection of
beneficiary minimum essential nursing data, with reliability and validity, and used in the waiver since 1993 and
will be collected in the EHR as part of usual care. We
obtain variables for our study from the MDS-HC [34].
Stages of Implementation (SIC) is an 8-stage tool that
examines completion of activities during implementation,
adoption, and sustainability and will be collected from the
IFs monthly (months 2 through 12) [35, 36].
Fidelity We will examine fidelity to the implementation
strategies and the intervention.
Fidelity to the implementation strategies. An implementation strategy fidelity checklist measures number of
consented clinicians, number of completed readiness and
leadership assessments, number of clinicians trained,
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number of IF actions taken, and number of interdisciplinary coordination meetings and will be collected monthly
(months 2 through 12). Based on a review of the literature,
IF actions will be coded as training, coaching, consultation, supervision, modeling, problem solving, providing feedback, supporting, instructing, demonstrating,
and assisting with evaluation. Clinician and facilitator
training acceptability will be evaluated by number of clinicians and facilitators who completed training. Costs of implementation will be estimated based on the time spent
training and increased number of home visits. Policy impact will be examined in the waiver contract.
Fidelity to the intervention. An intervention fidelity
checklist will be used to examine the EHR for those
beneficiaries who consent and receive care from trained
clinicians. This will include OT assessments at baseline;
SW mood assessment, as needed; and RN medication reviews and will be collected monthly (months 2 through
12). In addition, within the person-centered service plan,
we will examine the presence of the beneficiary’s desires
and needs being documented. Within progress notes
documentation, we will examine use of brainstorming,
problem solving, and role modeling.
Outcomes Primary outcomes are implementation strategy impact on adoption and sustainability of the intervention. Stages of implementation completion will be
derived via 3 SIC scores. First, the number of stages
completed is a simple count of progression through
stages; the score is the last stage in which at least one
activity was performed. Second, time spent in each stage
is calculated by taking the difference between the date of
completion of the first activity in the stage and the date
of completion of the last activity in the same stage.
Skipped activities are not included. If a site skips the last
activity in a stage and completes an activity in a subsequent stage, they automatically move to the subsequent stage. However, if they later complete the
skipped activity, the duration score is adjusted for the
original (earlier) stage to include the activity. Third, the
date of completion of all stages is logged within stage 8.
For sites that choose to discontinue implementation at
any point in the process, the date is logged in the furthest stage that the site enters. In the case where data
are summarized before the stage is complete but a site
has not discontinued implementation, the site data are
treated as being censored, just as it would in a standard
time-to-event or survival analysis [37]. Proportion of
activities completed is calculated as the number of
activities completed divided by the number of possible
activities in each stage. Activities in each stage are ordered based on their logical progression up to the last
activity the site completes in the stage or completion of the
final activity in the stage. Achievement of either activity
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indicates completion of that stage. Secondary outcomes are
intervention effects on beneficiary ADLs, IADLs, pain,
depression, falls, ED visits, and hospitalizations.
Sample size and power calculation

Site sample size was based on the number of available
sites, with 9 randomized to each arm. Assuming correlation of 0.7 between pairs of 11 repeated measures, the
adjusted effect size of 1.2 was detectable with power of
0.80 or greater in two-sided tests at 0.05 level of significance. The effect size is expressed as Cohen's d, difference
between trail arm means in standard deviation units. If
observed differences are smaller than 1.2 of the standard
deviation, statistical significance will not be reached, then
the estimate of the effect size will be obtained. For beneficiary outcomes, we assumed 750 beneficiaries per site and
conservative intraclass correlation coefficient of 0.01 to
obtain the design effect factor of 8.49. In the comparison
of the trial arms, the adjusted sample size is 795 per trial
arm, which allows to detect effect size as small as 0.14. As
larger effects were seen in the prior studies, a third of the
standard deviation or larger is often used as a threshold
for clinical significance [38, 39]. Small effects could be
detected as statistically significant, and the study is powered to detect any meaningful differences between IF and
IF + EF on beneficiary outcomes. The tests of mediation
effects (aim 2) will have a greater power as further reduction in error variance will occur due to controlling for
the mediator. Outcomes (aim 3) are benchmarked against
a prior period and have no hypotheses; thus, power
considerations are not applicable. Similarly, exploratory
aims have no associated hypotheses.
Randomization

Randomization will occur at the site level. The number
of beneficiaries and quality assessment scores will be
used to block the 18 sites into a pair of similar attributes.
A coin will be flipped to determine arm assignment of
each pair. We expect to start one pair each month until
all are underway.
Blinding

Clinicians and beneficiaries will be blinded to arm assignment. Sites, IFs, and research assistants will not be
blinded. Success of blinding will be assessed at study end.
Study procedures

After IRB approval, data use agreements will be obtained
and contracts will be executed with the sites, the state, and
the EHR company. To randomize, the sites’ number of
beneficiaries and summed quality data scores (2015–2017)
will be obtained from the state and the investigators will
match site pairs and assign the trial arm. If the clinicians
consent, characteristics, ILS, ORC, GSE, and EBPAS
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will be collected via survey (baseline). Waiver directors
and investigator will select IFs. Clinicians, IFs, and EFs
will be trained. The intervention will be provided to
beneficiaries and documented in the EHR (12 months
post-implementation). Monthly for 11 months following
implementation, the SIC (via research assistant phone
interview) and intervention fidelity checklist (via project
manager chart audit) will be collected. Clinician EBPAS
and GSE will be collected again via survey (9 months). We
will obtain beneficiary assessment data prior to the intervention (last assessment before implementation), after the
intervention (first assessment within 12 months postimplementation), and any assessments that occurred
between the two time points after completion of implementation via a data use agreement. Analysis will occur
and reports will be written.
Research assistant training

Research assistants will complete human subject training
and orientation prior to collecting data or interacting with
IFs. As part of orientation, a job description, which
includes the role and responsibilities, will be reviewed and
signed; a position manual, the manual of procedures, the
data safety monitoring plan and board charter, the study
protocol, the literature supporting project evidence and
approach, and the quality assurance-monitoring plan will
be reviewed. Research assistants will conduct dummy data
collection until performed correctly, prior to data
collection for the trial. Once trained, the research
assistant will participate in team meetings and quality
assurance activities and complete a weekly report of
activities and/or issues that arise.
Analytic approach

Preliminary analysis of the distributions of outcomes,
mediators, and potential covariates will be assessed, outliers will be investigated by inspecting the residuals, and
models described below will be fit with and without outliers to examine their influence on the results. Analyses
will be implemented in SAS 9.4.
Aim 1 primary outcomes (adoption and sustainability)
will be analyzed using a linear mixed effects model with repeated measures (SIC and EHR 12-months; IF 9-months).
Covariates will include trial arm, randomization variables,
and time entered as a class variable to model potentially
non-linear patterns. We will use a general linear model to
analyze training fidelity. Log-rank test and Cox proportional hazard modeling will be employed to analyze time
spent in each implementation stage. Tests of significance of
the coefficient of the trial arm variable will yield the formal
test of hypothesis for the effect of IF + EF compared to IF
alone. Analysis of beneficiary outcomes will employ a generalized linear model with appropriately distributed errors
and the random effect of site added to account for nesting
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of individuals within sites. For counts of falls and health
service use, Poisson error distribution will be specified.
Alternatively, a zero-inflated Poisson or negative binomial
model based on the distribution of the counts will be fit.
Explanatory variables, including trial arm, will be evaluated
as predictors of zero inflation (whether or not the count is
zero) and as predictors of the magnitude of the count when
it is not zero. Prior MDS will be used to obtain baseline
data for each outcome, which will be included as a covariate to explain the variation in post-intervention outcomes.
Aim 2 determines whether the effects of IF + EF compared to IF alone on adoption and sustainability are mediated by clinician attitude or self-efficacy at 9 months.
The model fit will be at the clinician level with site as a
random effect to account for nesting of clinicians within
sites. To test for mediation, trial arm will be treated as the
independent variable, with each potential mediator (one at
a time) tested for their effect on the outcome. A biascorrected bootstrapping analytic strategy [40, 41] will be
used to estimate confidence intervals around the indirect
effect of the trial arm on the outcome variable through
the mediator. To establish mediation, the 95% confidence
interval around the indirect must not include 0.
Aim 3 benchmarks the effects of IF + EF compared to
IF alone on beneficiary outcomes following implementation as compared to pre-intervention. Analysis will use
2 repeated measures of beneficiary outcomes, prior to
and 12 months after the intervention. Time by trial arm
interaction will be included. The least square means
according to the interaction term will be output from
this model, and differences from before and after the
intervention will be evaluated for each arm to gauge the
magnitude and meaning of improvements.
Exploratory aims. Aim 4 compares potential mediators
at 9 months and baseline leadership and readiness for
sites with SIC (> 50% to < 50%) at 6 months by arm.
General or generalized linear models (as appropriate
based on outcome or potential mediator distribution)
will include the binary indicator of whether SIC at 6
months (> 50% or < 50%) in interaction with the trial
arm variable. Differences between least square means
according to SIC level will be tested within each arm, and
the effect sizes will be estimated. Aim 5 explores whether
baseline site leadership and readiness moderate the impact
of IF + EF compared to IF alone on primary and secondary outcomes within 12 months in order to determine
which sites may require facilitation that is more intensive.
A model similar to aim 1 will be modified to include trial
arm by potential moderator interaction. Effect sizes that
correspond to the interaction term will be estimated. Aim
6 evaluates clinician satisfaction at 1 month and the cost
of implementation and policy impact for IF + EF compared to IF alone at 12 months. We will use descriptive
statistics to summarize satisfaction with training and
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implementation cost. We will use qualitative thematic
analysis to analyze the surveys. We will report on the
policy in the state contract.

Discussion
This trial sets an ambitious agenda to explore ways to
adopt and sustain evidence across a Medicaid program.
There is a significant amount of work that presents
challenges and opportunities. First, implementation and
evaluation with a hybrid III design in an under-resourced
real-world setting force a delicate balance of study design
and voluntary participation. Our work with sites in a standardized manner encourages local adaptations to optimize
implementation. Second, our selection of volunteer sites
may limit heterogeneity in our sample. However, we
expect to learn a great deal about stages of implementation to inform this project’s adoption and sustainability
that may be generalizable to other settings or populations.
Third, our measurement approach involves significant
effort in data collection of sites, clinicians, and beneficiaries with surveys, interviews, and extraction of
secondary administrative and clinical data across disparate
clinician contexts. The challenges of data collection and
management may be outweighed by the opportunity to
generate a broader understanding in Medicaid settings to
facilitate effective use of evidence in under-resourced,
complex environments.
Additional files
Additional file 1: Certification program training outline. An outline
of the training modules for the certification program. (PDF 72 kb)
Additional file 2: Pocket card algorithm. A cognitive aid on a packet card
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